#USA #Irvine #Skin Care #Epicutis #Hydrobiome Serum

Epicutis Unveils Hydrobiome Serum: A Breakthrough in Skin Care

Epicutis®, a cutting-edge skincare brand driven by innovative biotechnology from Signum Biosciences, has introduced its latest offering, Hydrobiome Serum. This new formulation promises significant enhancements in skin appearance while ensuring a gentle experience—zero reported irritation among users.

In a comprehensive clinical study conducted by Princeton Consumer Research, 48 subjects participated in an 8-week double-blind, placebo-controlled trial. The findings were impressive: participants using Hydrobiome Serum, centered on the active ingredient TCP, displayed a remarkable 77% improvement in overall skin appearance, outpacing the comparator group with a 56% enhancement and showing no measurable improvement in the control group. Importantly, none of the participants reported issues such as irritation, dryness, or discomfort, highlighting the product's exceptional tolerability.

A New Perspective on Skin Conditions

Conventional treatments for skin redness, congestion, and uneven texture often rely on aggressive methods, focusing on symptoms rather than addressing root causes. Many patients mistakenly turn to products designed for acne or oiliness, inadvertently escalating their issues. Hydrobiome Serum redefines this approach by emphasizing skin balance over skin type. It posits that factors such as environmental stress, excess sebum production, and weakened barrier function contribute more significantly to skin conditions than genetics.

The Hydrobiome Serum aims to tackle these underlying dynamics, leading to visibly clearer, calmer, and more resilient skin over time. Unlike traditional acid or retinoid-heavy treatments that can provoke inflammation, Epicutis champions a more thoughtful pathway. Founder and CEO Maxwell Stock states, “Hydrobiome Serum represents a smarter approach to fostering healthy-looking skin. Our patented technology allows the skin to operate as intended—well-balanced, resilient, and self-regulating.”

Dive Deeper into the Science

At the heart of Hydrobiome Serum is TCP (Tetrahydrocurcuminoids), a patented isoprenyl cysteine compound resulting from over ten years of meticulous research into lipid signaling at the cellular membrane level. This active ingredient, covered by U.S. patent 8,372,884, regulates cellular signaling, aiding the skin in maintaining its natural balance without suppressing immune activity broadly, which can lead to adverse effects.

TCP works synergistically with sodium tocopheryl phosphate (TPNa), a water-soluble Vitamin E, revered for its antioxidant benefits and ability to enhance skin barrier protection without clogging pores. Together, they promote:

• - Maintenance of skin barrier integrity
• - Balanced hydration without occlusion
• - Visible reduction of redness and irritation
• - A consistently balanced complexion with daily use

Tolerability and Clinical Performance

The study validates Hydrobiome Serum’s superior performance:

• - TCP Group: 77% improvement in overall skin appearance from baseline.
• - Comparator: 56% improvement in overall skin appearance.
• - Vehicle Control: No measurable improvement.

Moreover, every participant in the TCP group reported a comfortable experience with zero adverse effects like irritation or dryness, positioning Hydrobiome Serum effectively against the typical issues faced with skincare interventions.

Exclusivity in Distribution

To maintain its commitment to physician-driven integrity and patient outcomes, Hydrobiome Serum will be available exclusively through licensed aesthetic professionals, dermatology practices, and accredited med-spas, veering away from mass retail distribution channels. Epicutis suggests pairing Hydrobiome Serum with their Hydrobiome Mist to optimize hydration and maintain skin balance.

Professionals interested in offering Hydrobiome Serum can explore the Epicutis professional portal for order details, clinical samples, and patient education materials.

About Epicutis

Epicutis stands as a pioneering professional skincare brand that emphasizes skin health over age, utilizing patented ingredients developed through rigorous scientific research. Their formulations are designed to reinforce the skin barrier, minimize visible irritation, and foster overall skin balance while adhering to transparency standards, indicated by their EWG Verified® status. Available only through professional channels, Epicutis confirms its dedication to quality and efficacy.

Learn more about Hydrobiome Serum and other products at Epicutis.com.

About Signum Biosciences

Signum Biosciences is a biotech leader focused on developing innovative isoprenyl cysteine compounds that influence cellular regulation pathways crucial for skin health. The company holds multiple U.S. patents that support their groundbreaking work across dermatological and inflammatory fields.

All claims are based on clinical study data from Princeton Consumer Research. Epicutis® is a registered trademark of Signum Dermalogix, Inc.